Fresenius Medical Care’s Acquisition of Ciame Ltda

Hughes & Hughes and Eguren y Asociados advised on the deal

Fresenius Medical Care has acquired the company Ciame Ltda, a leading distributor in Uruguay, which has been commercializing the company’s product portfolio to a large number of patients with chronic kidney disease for more than 18 years.

With this acquisition, Fresenius Medical Care aims to introduce new technologies and knowledge to the Uruguayan market, expand the local distribution of its products and thus make the best therapies available to more patients with kidney disease throughout the region.

Fresenius Medical Care AG & Co. KGaA offers kidney dialysis services and manufactures and distributes equipment and products used in the treatment of dialysis patients. The Company, led by Rice Powell, Helen Giza and Olaf Schermeier also offers clinical laboratory testing and diagnostic testing services and provides home infusion, respiratory therapy, ultrasound, and echo-cardiography. Fresenius operates worldwide and in 2018 recorded €16.54 Billion revenues.

Hughes & Hughes advised Fresenius with a team led by Héctor Ferreira (Picture) and including Analía Fernández, Santiago Di Bello, Patricia Villalba, Lucas Galluzzo and Magdalena Castagno.

Eguren y Asociados advised Ciame Ltda

Involved fees earner: Héctor Ferreira – Hughes & Hughes Abogados;

Law Firms: Hughes & Hughes Abogados;

Clients: Fresenius Medical Care AG & Co. KGaA;

Author: Ambrogio Visconti.